Avoro Capital Advisors LLC Merus N.V. Transaction History
Avoro Capital Advisors LLC
- $5.48 Billion
- Q2 2025
A detailed history of Avoro Capital Advisors LLC transactions in Merus N.V. stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 3,155,555 shares of MRUS stock, worth $201 Million. This represents 3.03% of its overall portfolio holdings.
Number of Shares
3,155,555
Previous 3,000,000
5.19%
Holding current value
$201 Million
Previous $126 Million
31.45%
% of portfolio
3.03%
Previous 2.04%
Shares
10 transactions
Others Institutions Holding MRUS
# of Institutions
217Shares Held
65.3MCall Options Held
311KPut Options Held
556K-
Paradigm Biocapital Advisors LP New York, NY4.28MShares$273 Million10.51% of portfolio
-
Rtw Investments, LP New York, NY4MShares$255 Million3.23% of portfolio
-
Wellington Management Group LLP Boston, MA3.73MShares$238 Million0.04% of portfolio
-
Commodore Capital LP New York, NY3.53MShares$225 Million17.29% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.38MShares$216 Million4.09% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.93B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...